An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.
Winston DunnYanming LiAshwani K SingalDouglas A SimonettoLuis A DíazFrancisco IdalsoagaGustavo AyaresJorge ArnoldMaría Ayala-ValverdeDiego PerezJaime GomezRodrigo EscarateEduardo Fuentes-LópezCarolina Ramirez-CadizDalia Morales-ArraezWei ZhangSteve QianJoseph C AhnSeth BuryskaHeer MehtaNicholas DunnMuhammad WaleedHoria StefanescuAndreea BumbuAdelina HorhatBashar AttarRohit AgrawalJoaquin CabezasVictor EchavaríaBerta CuyàsMaría PocaGerman SorianoShiv K SarinRakhi MaiwallPrasun Kumar JalalFátima Higuera-de-la-TijeraAnand V KulkarniP Nagaraja RaoPatricia Guerra-SalazarLubomir SkladanyNatália KubánekVeronica PradoAna Clemente-SanchezDiego RinconTehseen HaiderKristina R ChackoGustavo A RomeroFlorencia D PollarskyJuan Carlos Restrepo GutierrezLuis G ToroPamela YaquichManuel MendizabalMaria L GarridoSebastián MarcianoMelisa DirchwolfVíctor VargasCesar JiménezDavid HudsonGuadalupe García-TsaoGuillermo OrtizJuan G AbraldesPatrick S KamathMarco ArreseVijay H ShahRamon A BatallerJuan Pablo ArabPublished in: Hepatology (Baltimore, Md.) (2024)
Harnessing AI within a global consortium, we pioneered a scoring system excelling over traditional models for 30 and 90-day AH mortality predictions. Beneficial for clinical trials, steroid therapy, and transplant indications, it's accessible at: https://aihepatology.shinyapps.io/ALCHAIN/.